United States: Ebola Matters Of First Impression; Law Lags Behind Policy

While we turn to science and laws to guide our response to matters in the healthcare industry, the entrance of the Ebola virus into our lives here in the U.S. has challenged our abilities, both from a medical and legal perspective. We know what to do, but our abilities to respond adequately, timely and responsibly have been delayed. In some cases, the coordination of care, resources and response requires a new way of thinking and breaking down silos existing in our public health and government agencies. The U.S. houses the most skilled experts in infectious disease and prevention, as well as the capacity to respond appropriately to this new infectious threat.

The Ebola Virus

It is our responsibility, first and foremost, to ensure that accurate information is transmitted relating to the Ebola virus itself. It is most essential that we understand the epidemiology of the disease to help our clients appropriately prepare and respond.

All infectious disease experts indicate that while the Ebola virus is a serious infectious disease, it is not that hearty. According to the Centers for Disease Control and Prevention (CDC), it can be killed with bleach and hospital grade disinfectants. The virus is not airborne and can only be spread by an individual who has an active illness. Individuals are only contagious when they start showing symptoms, which include fever, muscle weakness, severe headache and (6-8 days after fever) diarrhea, vomiting, bleeding and bruising. It is only contact with bodily fluids, like blood, vomit, urine, sweat, saliva, tears, etc., that will spread the disease.

Therefore, healthcare workers are at heightened risk of transmission and the average public is not. It is our obligation to ensure this is widely understood to help contain unnecessary panic, but more importantly, focus our resources to help our healthcare workers and institutions appropriately prepare and manage the anticipated response to this virus.

Resources

Since the first patient was diagnosed and treated in Texas, several important steps have been taken to heighten the response in Texas and around the nation. The CDC has been actively updating its recommended protocols on its website since the first patient presented here in the U.S. Early identification and transfer of a patient to a higher level of care also is critical to prevent transmission of the disease. The CDC has produced an algorithm for the evaluation of a returned traveler and a checklist for patients evaluated for Ebola in the U.S., as well as information relating to caring for a suspected Ebola patient. In addition, The Joint Commission has produced several Ebola and emergency management protocols.

There are four hospitals in the U.S. that have established biocontainment units:

  • Emory Healthcare, Atlanta, Georgia
  • National Institutes of Health, Bethesda, Maryland
  • St. Patrick Hospital, Missoula, Montana
  • University of Nebraska Medical Center, Omaha, Nebraska

In addition, both Emory Healthcare and the University of Nebraska Medical Center have shared their Ebola preparedness protocols with the public and the CDC.

While all four facilities have been accessed to care for individuals diagnosed with the Ebola virus and have successfully treated these patients, it is clear that every hospital is expected to have the capacity to recognize, detect and isolate a patient. Special isolation procedures and units need to be identified and significant training of personnel must ensue. To that end, the CDC has sent what it refers to as "FAST" teams to Texas, New York, Illinois and Virginia to work with hospitals that have indicated a willingness to care for Ebola patients.

Additionally, the CDC is considering a plan aimed at creating a regional and tiered hospital approach to Ebola patient care, and several state governors and local officials have begun this undertaking. For example, the Texas governor recently identified two facilities that will serve as referral centers for the treatment of Ebola patients and has appointed a Task Force on Infectious Disease Preparedness and Response that produced specific recommendations on October 17, 2014.

Critically, the special capacity for pediatrics has been identified as a specific need. In Illinois, the mayor of Chicago, Rahm Emanuel, and the Chicago Department of Public Health announced the formation of a network of resource centers that is preparing to provide care for Ebola patients in Chicago, which includes one pediatric facility and three other adult acute care providers working together to coordinate their response and establish best practices, protocols and appropriately trained personnel.

On October 20, 2014, the CDC updated its guidelines for healthcare workers, involving recommendations for Personal Protective Equipment (PPE). The "donning and doffing" (putting the gear on and taking it off) of PPE is a critical safety component in the management of Ebola patients. One of the most confounding issues to date has been the practical concern that PPE is not widely or readily available due to a significant backlog of requests and orders. This raises the question of how can the production and purchase of PPE be expedited—especially for facilities identified as designated referral centers for suspected Ebola cases? At the time of publication, we are unaware of any official recognition of the need to expedite the purchase and processing of requests for PPE and other special supplies for facilities in cities identified as likely entry points and resource centers for Ebola patients. This situation also has worked to impede the ability of many facilities to train and drill clinical staff in the safe and effective donning and doffing of PPE.

Hospitals also have seemingly been left on their own in addressing many of the practical issues associated with managing the treatment team. For example, how to address the limitations inherent in the PPE's ability to accommodate every body type, as well as physical limitations and medical conditions that may necessitate a clinical worker's withdrawal from the treatment team. Our advice has been to ensure the health and safety of the healthcare workers, and if such safety may be compromised due to their physical or other limitations, such individuals should not be included in the first line care of Ebola patients.

Issues involving the use of medical trainees, such as residents and interns, have arisen, since they are usually present in the emergency room and around the hospital on various rotations and, in fact, may be among the first individuals to have contact with a patient. While the Accreditation Council for Graduate Medical Education (ACGME) has put out guidance expecting that such students will be properly trained and supervised, many medical schools have determined that its students and residents should not be allowed to treat Ebola patients. Thus, training for residents and interns will be important to ensure identification of the disease, even if further care in other areas of the hospital may be restricted.

Medical waste disposal is another primary concern due to the sheer volume and virulence of the waste caused by the Ebola virus. In Texas, the U.S. Department of Transportation (DOT) worked with state and local officials in granting special waivers for the packaging, transport and disposal of medical waste (including sheets, towels, curtains, PPE and other things that do not typically fall within a Category A type waste stream). The U.S. Department of Health and Human Services (HHS) has acknowledged this issue and on a recent hospital preparedness call held by the Assistant Secretary for Preparedness and Response at HHS, the DOT indicated that it has since worked with several waste carriers across the country, Stericycle, Veolia as well as the CDC, to develop a waste packaging system and non-site-specific waiver to transport accumulated waste from anywhere in the country. The DOT's Pipeline and Hazardous Materials Safety Administration has posted a safety advisory notice and guidance to its website that prescribes best practices on packaging suspected Ebola contaminated waste.

Quarantine Laws

Most prominently, the legal issues of quarantine have arisen for the first time in many years. The ability of the state and federal government to protect the general health and welfare of its citizens comes into conflict with our notion of personal liberties. This will be an issue we will hear and see more of as various state legislatures convene and the medical community works to contain the virus.

Each state has its own set of quarantine laws, the rights and powers of which also differ by state. While a majority of states authorize quarantine by the department of health, others empower the public health officer to order quarantine or require a judicial order from the courts. Although many states have worked to update their public health laws, they have lagged behind with quarantine laws, some of which may date back more than 100 years. Inconsistencies between state public health and quarantine laws will become more obvious as a greater number of states confront the issue of healthcare workers returning from West Africa. One approach, and a vehicle that already exists, is the Model State Emergency Health Powers Act, which was proposed as a state standard for comprehensive public health quarantine and emergency powers laws.

The federal government has the authority to issue quarantine under certain circumstances identified in the Public Health Services Act. Such authority exists under the Commerce Clause of the U.S. Constitution and focuses on the prevention of the introduction of communicable diseases from foreign countries and transmission between states, if the state response is found to be insufficient. The role of the CDC is a direct relation to this power and the interplay between federal and state quarantine authority has been the subject of daily reports in the press.

In Texas, the state health department had the authority to issue quarantine, known as a "control order," applicable to individuals and property since the first patient presented to the emergency room in Dallas. The state's Health and Human Services commissioner chose not to issue the control order initially, electing first to allow individuals to self-monitor. Many have criticized this action. In fact, to date, governors in New York, New Jersey and Illinois have more readily used their state's quarantine authority after the experience in Dallas. The quarantine of healthcare workers and individuals suspected of carrying the disease will be governed by the quarantine laws of each state.

The Texas Task Force on Infectious Disease Preparedness and Response in its recommendations, indicated that these quarantine laws be improved and strengthened to allow authorized enforcement of the control orders. Currently, Texas control order authority does not allow the commissioner the authority to enforce the order via law enforcement if the individual leaves the designated premises and moves into the public domain. Thus, the issues of personal freedom vs. public health once again are thrust into the limelight and likely will be debated in legislatures across the U.S.

For now, we are limited by our laws and the judgment of public health authorities in state and local government to ensure that we practically produce and disseminate capital, intellectual, medical and hard asset resources to allow our hospitals, physicians, nurses and facilities experts to help quell this disease in the U.S. and export our knowledge in a more robust way to those countries more seriously impacted.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions